Alcon: Alcon Reports First Quarter 2025 Financial Results and Updated Full-Year Guidance

GENEVA, Switzerland-Alcon (SIX/NYSE:ALC), a global leader in eyecare, has announced its financial results for the three months ending March 31, 2025. For the first quarter of 2025, sales were $2.5 billion, flat on a reported basis and up 3 percent on a constant currency basis, as compared with the same quarter of the previous year, the company stated. Vision care net sales, which include contact lenses and ocular health, were reported at $1.1 billion for the first quarter of 2025, an increase of 1 percent on a reported basis and 3 percent on a constant currency basis compared with the first quarter of 2024. The company also announced the recent launch of several ophthalmic products.